These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24554450)

  • 1. Diagnosis and workup of 522 consecutive patients with neuroendocrine neoplasms in Switzerland.
    Gouffon M; Iff S; Ziegler K; Larche M; Schwarzenbach C; Prior JO; Matter M; Stettler C; Pralong FP
    Swiss Med Wkly; 2014 Feb; 144():w13924. PubMed ID: 24554450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additional malignancies in patients with neuroendocrine tumours: analysis of the SwissNET registry.
    Kollár A; Blank A; Perren A; Bütikofer L; Stettler C; Christ E
    Swiss Med Wkly; 2016; 146():w14362. PubMed ID: 27878790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Neuroendocrine Neoplasms of the Digestive Tract: Diagnosis, Treatment and Nutrition.
    Pobłocki J; Jasińska A; Syrenicz A; Andrysiak-Mamos E; Szczuko M
    Nutrients; 2020 May; 12(5):. PubMed ID: 32429294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digestive neuroendocrine tumours: diagnosis and treatment in Italy. A survey by the Oncology Study Section of the Italian Society of Gastroenterology (SIGE).
    Corleto VD; Panzuto F; Falconi M; Cannizzaro R; Angeletti S; Moretti A; Delle Fave G; Farinati F;
    Dig Liver Dis; 2001 Apr; 33(3):217-21. PubMed ID: 11407665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone metastases in patients with neuroendocrine tumor: 68Ga-DOTA-Tyr3-octreotide PET in comparison to CT and bone scintigraphy.
    Putzer D; Gabriel M; Henninger B; Kendler D; Uprimny C; Dobrozemsky G; Decristoforo C; Bale RJ; Jaschke W; Virgolini IJ
    J Nucl Med; 2009 Aug; 50(8):1214-21. PubMed ID: 19617343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent developments in the diagnosis and therapy of well-differentiated neuroendocrine tumours.
    Hofland J; Feelders RA; Brabander T; Franssen GJH; de Herder WW
    Neth J Med; 2018 Apr; 76(3):100-108. PubMed ID: 29667585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment sequence in patients with neuroendocrine tumours: a nationwide multicentre, observational analysis of the Swiss neuroendocrine tumour registry.
    Kollar A; Bütikofer L; Ochsenbein A; Stettler C; Trepp R
    Swiss Med Wkly; 2020 Jan; 150():w20176. PubMed ID: 31940430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous 68Ga-DOTATOC PET/MRI in patients with gastroenteropancreatic neuroendocrine tumors: initial results.
    Beiderwellen KJ; Poeppel TD; Hartung-Knemeyer V; Buchbender C; Kuehl H; Bockisch A; Lauenstein TC
    Invest Radiol; 2013 May; 48(5):273-9. PubMed ID: 23493121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Octreotide suppression test in diagnosing and predicting the outcome of therapy in patients with neuroendocrine tumors. Preliminary report.
    Kos-Kudła B; Zemczak A; Foltyn W; Marek B; Strzelczyk J; Telega A; Zajecki W; Legaszewski T; Jurecka-Lubieniecka B
    Endokrynol Pol; 2007; 58(2):123-9. PubMed ID: 17578828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroendocrine neoplasms of the small intestine and appendix - management guidelines (recommended by the Polish Network of Neuroendocrine Tumours).
    Bednarczuk T; Bolanowski M; Zemczak A; Bałdys-Waligórska A; Blicharz-Dorniak J; Boratyn-Nowicka A; Borowska M; Cichocki A; Ćwikła JB; Falconi M; Foltyn W; Handkiewicz-Junak D; Hubalewska-Dydejczyk A; Jarząb B; Junik R; Kajdaniuk D; Kamiński G; Kolasińska-Ćwikła A; Kowalska A; Król R; Królicki L; Kunikowska J; Kuśnierz K; Lampe P; Lange D; Lewczuk-Myślicka A; Lewiński A; Lipiński M; Londzin-Olesik M; Marek B; Nasierowska-Guttmejer A; Nowakowska-Duława E; Pałucki J; Pilch-Kowalczyk J; Rosiek V; Ruchała M; Siemińska L; Sowa-Staszczak A; Starzyńska T; Steinhof-Radwańska K; Strzelczyk J; Sworczak K; Syrenicz A; Szawłowski A; Szczepkowski M; Wachuła E; Zajęcki W; Zgliczyński W; Kos-Kudła B
    Endokrynol Pol; 2017; 68(2):223-236. PubMed ID: 28540974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digestive Neuroendocrine Neoplasms (NEN): French Intergroup clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, GTE, RENATEN, TENPATH, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR).
    de Mestier L; Lepage C; Baudin E; Coriat R; Courbon F; Couvelard A; Do Cao C; Frampas E; Gaujoux S; Gincul R; Goudet P; Lombard-Bohas C; Poncet G; Smith D; Ruszniewski P; Lecomte T; Bouché O; Walter T; Cadiot G;
    Dig Liver Dis; 2020 May; 52(5):473-492. PubMed ID: 32234416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neuroendocrine tumours of the GI tract--data from the German NET Registry].
    Begum N; Maasberg S; Plöckinger U; Anlauf M; Rinke A; Pöpperl G; Lehnert H; Izbicki JR; Krausch M; Vashist YK; Raffel A; Bürk CG; Hoffmann J; Goretzki P; Pape UF;
    Zentralbl Chir; 2014 Jun; 139(3):276-83. PubMed ID: 23042103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostics and therapy for neuroendocrine neoplasia of an unknown primary - a plea for open exploration].
    Begum N; Hubold C; Buchmann I; Thorns C; Bouchard R; Lubienski A; Schlöricke E; Zimmermann M; Lehnert H; Bruch HP; Bürk CG
    Zentralbl Chir; 2014 Jun; 139(3):284-91. PubMed ID: 23508839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroendocrine neoplasms of the small intestine and the appendix - management guidelines (recommended by the Polish Network of Neuroendocrine Tumours).
    Bolanowski M; Bednarczuk T; Bobek-Billewicz B; Handkiewicz-Junak D; Jeziorski A; Nowakowska-Duława E; Steinhof-Radwańska K; Zajęcki W; Zemczak A; Kos-Kudła B; ;
    Endokrynol Pol; 2013; 64(6):480-93. PubMed ID: 24431119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive Value of 99MTC-hynic-toc Scintigraphy in Lung Neuroendocrine Tumor Diagnosis.
    Boutsikou E; Porpodis K; Chatzipavlidou V; Hardavella G; Gerasimou G; Domvri K; Papadopoulos N; Avramidou V; Spyratos D; Kontakiotis T; Zarogoulidis K
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819842586. PubMed ID: 31079574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin-receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors.
    Kwekkeboom DJ; Kam BL; van Essen M; Teunissen JJ; van Eijck CH; Valkema R; de Jong M; de Herder WW; Krenning EP
    Endocr Relat Cancer; 2010 Mar; 17(1):R53-73. PubMed ID: 19995807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of 18F-dopa PET/CT imaging in the management of patients with 111In-pentetreotide negative GEP tumours.
    Ambrosini V; Tomassetti P; Rubello D; Campana D; Nanni C; Castellucci P; Farsad M; Montini G; Al-Nahhas A; Franchi R; Fanti S
    Nucl Med Commun; 2007 Jun; 28(6):473-7. PubMed ID: 17460538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of feasibility and image quality of 68Ga-DOTATOC positron emission tomography/magnetic resonance in comparison with positron emission tomography/computed tomography in patients with neuroendocrine tumors.
    Gaertner FC; Beer AJ; Souvatzoglou M; Eiber M; Fürst S; Ziegler SI; Brohl F; Schwaiger M; Scheidhauer K
    Invest Radiol; 2013 May; 48(5):263-72. PubMed ID: 23385399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating Transcript Analysis (NETest) in GEP-NETs Treated With Somatostatin Analogs Defines Therapy.
    Ćwikła JB; Bodei L; Kolasinska-Ćwikła A; Sankowski A; Modlin IM; Kidd M
    J Clin Endocrinol Metab; 2015 Nov; 100(11):E1437-45. PubMed ID: 26348352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The scintigraphy of somatostatin receptors in the carcinoid tumor].
    Banzo J; Abós MD; Prats E; Delgado M; Razola P; García S; Gomollón F; García F
    Rev Esp Med Nucl; 2001 Feb; 20(1):11-8. PubMed ID: 11181324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.